Jane Street’s TriSalus Life Sciences TLSI Stock Holding History

Jane Street’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-657,389	Closed	-$6.53M	–	10151
2022 Q3	$6.53M	Buy	657,389 +203,706	+45%	+$2.02M	﹤0.01%	2213
2022 Q2	$4.47M	Buy	453,683 +16,893	+4%	+$166K	﹤0.01%	2842
2022 Q1	$4.28M	Buy	436,790 +347,119	+387%	+$3.43M	﹤0.01%	3301
2021 Q4	$886K	Buy	89,671 +72	+0.1%	+$715	﹤0.01%	6145
2021 Q3	$890K	Sell	89,599 -219	-0.2%	-$2.14K	﹤0.01%	6151
2021 Q2	$871K	Buy	89,818 +21,491	+31%	+$211K	﹤0.01%	6120
2021 Q1	$660K	Buy	+68,327	New	+$693K	﹤0.01%	6279

Other funds holding TLSI

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DFCM

Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's TLSI Position: Q4 2022 in Review

Jane Street sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 657,389 shares — an estimated $6.53M sold.

Jane Street first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $6.53M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

Jane Street reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
Jane Street sold 657,389 TriSalus Life Sciences shares in Q4 2022, an estimated $6.53M.
Jane Street first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
Jane Street's TriSalus Life Sciences position peaked at $6.53M in Q3 2022.
9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.